Tumour therapy
CA 2273218 A1 · Owner: Bagshawe, Kenneth Dawson · Inventors: Bagshawe, Kenneth Dawson
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A three component therapeutic system comprising (i) a first compound (ii) a , catalytic macromolecule which does not specifically bind to a tumour antigen but which is capable, following administration to the vascular compartment of a mammal, of being taken up by a tumour in the mammal and is capable of converting the first compound into a second compound and (iii) an inhibitor , which, following administration to the said vascular compartment reduces the , level of the said catalytic conversion activity in the vascular compartment.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 28, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 28, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 28, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.